Clinical Trials on AMD

Total 411988 results

Viron Therapeutics Inc
Vion Pharmaceuticals

Terminated

Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine

Acute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)

United States
Stanford University
Celgene Corporation

Terminated

Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDS

Leukemia | Myelodysplastic Syndromes (MDS) | Acute Myeloid Leukemia (AML)

United States
Merck Sharp & Dohme LLC

Completed

Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052) (TALL)

Myelodysplastic Syndrome | Leukemia, Acute Myeloid
AbbVie

Terminated

Study to Evaluate Adverse Events and Movement of Lemzoparlimab in Body When Used Intravenously (IV) With Azacitidine Subcutaneously or IV and Venetoclax Orally in Participants With Acute Myeloid Leukemia and With Azacitidine With or Without Venetoclax in Participants With Myelodysplastic Syndrome

Acute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)

United States, Australia, Germany, Israel, Italy, Japan, Spain
Mirati Therapeutics Inc.

Terminated

Phase 2 Study of Azacitidine (Vidaza) vs MGCD0103 vs Combination in Elderly Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Acute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)

United States, Canada, United Kingdom
University Hospital, Grenoble

Not yet recruiting

Technical Feasibility Study of Ultrasound Muscle Imaging in Antenatal Ultrasound (FetUS)

Arthrogryposis Multiplex Congenita (AMC)
Brown University

Completed

Mifepristone for the Prevention of Relapses of Alcohol Drinking

Alcohol Use Disorders (AUD)

United States
West Coast Retina Medical Group, Inc.
Genentech, Inc.

Unknown

Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy

Wet AMD

United States
Poxel SA

Not yet recruiting

Study to Assess PXL065 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD)

ALD (Adrenoleukodystrophy)
University of Oklahoma
Eli Lilly and Company; Mark L. Wolraich, M.D.

Completed

Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD (B4Z-MC-X017)

Attention Deficit Disorder With Hyperactivity (ADHD) | Attention Deficit Disorder (ADD) | Fetal Alcohol Syndrome

United States
Jing Liang

Recruiting

Correlation Between the Change of Peripheral Lymphocyte Subsets and Clinically Amyopathic Dermatomyositis Combined With Rapidly Progressive Interstitial Lung Disease

Clinically Amyopathic Dermatomyisitis(CAMD)

China
Patrick Stiff

Recruiting

Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS

Myelodysplastic Syndrome MDS | Acute Myelogenous Leukemia AML

United States
Cornerstone Pharmaceuticals

Withdrawn

Safety and Effectiveness Study of CPI-613 to Treat Refractory or Relapsed Leukemia and Myelodysplastic Syndrome

Acute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)

United States
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC

Completed

Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)

United States
AbbVie

Active, not recruiting

Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adolescent and Adult Chinese Participants With Atopic Dermatitis

Atopic Dermatitis (AD)

China
National Institute of Allergy and Infectious Diseases...
Sanofi; Regeneron Pharmaceuticals; Rho Federal Systems Division, Inc.; Atopic Dermatitis...

Terminated

Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis

Atopic Dermatitis (AD)

United States
AbbVie

Withdrawn

A Study of Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in Brazil

Atopic Dermatitis (AD)
Regeneron Pharmaceuticals
Sanofi

Completed

Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)

Atopic Dermatitis (AD)

United States, Canada
Otsuka Beijing Research Institute

Recruiting

To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD

Atopic Dermatitis (AD)

China
Johnson & Johnson Consumer Inc. (J&JCI)

Completed

Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With Eczema

Atopic Dermatitis (AD)

United States
Hannover Medical School
University Hospital, Ghent; Johann Wolfgang Goethe University Hospital; University... and other collaborators

Unknown

Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T

De Novo Akute Myeloid Leukemia (AML) | Secondary Acute Myeloid Leukemia (AML) | Refractory Anemia With Excess of Blasts in Transformation

Germany
Evergreen Therapeutics, Inc.

Not yet recruiting

Study to Evaluate Safety and Efficacy of EG-301 in Patients With Nonfocal Geographic Atrophy Secondary to dAMD

Non-Exudative (Dry) Age-related Macular Degeneration (dAMD)
Woebot Health
National Institute on Drug Abuse (NIDA); Stanford University

Completed

Pilot: Digital Therapeutic vs Education for the Management of Problematic Substance Use

Substance Use Disorders | Alcohol Use Disorder (AUD)

United States
University of Florida
National Institute on Alcohol Abuse and Alcoholism (NIAAA); American Psychological...

Terminated

Impulsivity and Alcohol Response (IDEA)

Alcohol Use Disorder (AUD) | Subjective Response to Alcohol (SR)

United States
Otsuka Beijing Research Institute

Recruiting

To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients With AD

Atopic Dermatitis (AD)

China
Otsuka Pharmaceutical Co., Ltd.

Completed

A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis

Atopic Dermatitis (AD)

Japan
Randy Windreich

Completed

Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS

Acute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS) | Hematopoietic Stem Cell Transplant (HSCT)

United States
Forest Laboratories

Terminated

Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Autistic Disorder | Autism | Asperger's Disorder | Autism Spectrum Disorder (ASD) | Asperger's | Pediatric Autism | Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

United States, Estonia, Hungary, Iceland, Italy, Korea, Republic of, Serbia, Ukraine, Canada, Colombia, Belgium, France, New Zealand, Poland, South Africa, Spain
Forest Laboratories

Completed

An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Autistic Disorder | Autism | Asperger's Disorder | Autism Spectrum Disorder (ASD) | Asperger's | Pediatric Autism | Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

United States, Belgium, Colombia, Estonia, Hungary, Iceland, Italy, Korea, Republic of, New Zealand, Poland, Serbia, South Africa, Spain, Ukraine, Australia, Canada, France, Singapore
Centre Hospitalier Universitaire Dijon

Unknown

COVID-19 Related Lockdown Effects On Chronic Diseases (CLEO-CD)

Heart Failure | Multiple Sclerosis | Hemophilia | Chronic Respiratory Failure | Horton's Disease | Chronic Coronary Syndrome | AMD and Macular Edema | Malignant Hemopathy

France
Moorfields Eye Hospital NHS Foundation Trust
King's College London; Cardiff University; University College, London; Newcastle... and other collaborators

Recruiting

Quality-Assured Follow-up of Quiescent Neovascular Age -Related maculaR dEgeneration by Non-medical Practitioners (FENETRE)

AMD

United Kingdom
Changhua Christian Hospital

Completed

Real World Outcomes of Intravitreal Anti-vascular Endothelial Growth Factors for Neovascular Age Related Macular Degeneration in Taiwan (OIVAEGFFAMDIT)

AMD

Taiwan
Regeneron Pharmaceuticals

Completed

Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection) (RE-VIEW)

Age - Related Macular Degeneration (AMD)

United States
Novartis Pharmaceuticals

Completed

Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Agerelated Macular Degeneration (AMD) Who Received Anti-VEGF Agents (IRIS Registry)

Age-related Macular Degeneration (AMD)

United States
The First Affiliated Hospital with Nanjing Medical...

Unknown

Treatment of Age-related Macular Degeneration by Fetal Retinal Pigment Epithelial Cells Transplantation

Macular Degeneration | Age Related Macular Degeneration | AMD

China
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Not yet recruiting

The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)

Alcohol-Related Disorders | Alcohol Use | Alcohol Use Disorder (AUD)

United States
Felix Mueller
University of Bern

Not yet recruiting

LSD Treatment for Persons With Alcohol Use Disorder (LYSTA)

Alcohol Use Disorder (AUD)

Switzerland
University of Pennsylvania

Recruiting

Ibudilast for Treating Alcohol Use Disorder (Ibudilast)

Alcoholism | Alcohol Use Disorder (AUD)

United States
University of Central Florida

Not yet recruiting

Mobile Rewarding Activity Centered Treatment (mReACT)

Alcohol Use Disorder (AUD)
University of Pennsylvania

Recruiting

Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use Disorder

Alcohol Drinking | Alcohol Use Disorder (AUD)

United States
Brown University

Recruiting

Alpha-1 Blockade for Alcohol Use Disorder (AUD) (DOXY)

Alcohol Use Disorder (AUD)

United States
Boston Medical Center
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Active, not recruiting

Records for Alcohol Care Enhancement (RACE)

Alcohol Use Disorder (AUD)

United States
Turning Point
St Vincent's Hospital Melbourne; Monash Health; Uniting Vic Tas; Star Health; Odyssey...

Active, not recruiting

AAT-App Outpatient Trial (AAT-App)

Alcohol Use Disorder (AUD)

Australia
University Hospital, Grenoble

Completed

Arthrogryposis Multiplex Congenita in Pediatric Age: Correlation Between MUScular MRI and Functional Evaluation (AMUSE)

Pediatric ALL | Arthrogryposis Multiplex Congenita | AMC-Arthrogryposis Multiplex Congenita

France
VA Office of Research and Development

Not yet recruiting

Combining a Smartphone App With Medications to Manage Heavy Drinking

Alcohol Use Disorder (AUD)

United States
University of Sydney
Monash University

Recruiting

A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use Disorder (NAC-AUD)

Alcohol Use Disorder (AUD)

Australia
Washington State University

Recruiting

The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study

Alcohol Use Disorder (AUD)

United States
SRI International
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Recruiting

Sleep and Emotional Reactivity in Alcohol Use Disorder (SEAS)

Alcohol Use Disorder (AUD)

United States
Virginia Polytechnic Institute and State University
Fralin Biomedical Research Institute

Recruiting

Real-Time fMRI to Enhance Interventions That Change Delay Discounting (RP2B)

Alcohol Use Disorder (AUD)

United States
St. Jude Children's Research Hospital

Active, not recruiting

CD123-Directed Autologous T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)

B-ALL | T-ALL | AML/MDS | BPDCN

United States

Clinical Trials on AMD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations